Navigation Links
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
Date:9/2/2008

LAI Post- Injection Syndrome cases observed in olanzapine LAI clinical trials to determine appropriate recommendations for risk and medical management. Safety data were pooled from all completed and ongoing olanzapine LAI clinical trials through 30 September 2007; adverse event data through 31 May 2008 were also reviewed.

As of 31 May 2008, the incidence of Olanzapine LAI Post-Injection Syndrome following administration of olanzapine LAI was 29 cases (in 28 patients) after more than 40,000 injections, yielding a per-injection rate of 0.07 percent and a per-patient rate of 1.4 per cent - or approximately one event per 1,400 injections. No clinically significant decreases in vital signs were observed and all patients recovered completely from signs and symptoms of Olanzapine LAI Post-Injection Syndrome within 1.5 to 72 hours. Approximately 70 percent of patients continued to receive injections after the event. The cumulative risk of experiencing an Olanzapine LAI Post-Injection Syndrome event after one year of treatment was 0.7 to 1.2 percent. (These data were presented as a range due to variable injection intervals).

Across all clinical trials, as of 31 July, no additional cases of Olanzapine LAI Post-Injection Syndrome were reported.

Based on the extensive review of pooled safety data from all olanzapine LAI clinical trials and given that awareness and recognition of these events are key aspects of identifying them and minimizing associated symptoms, Lilly has proposed a comprehensive plan for managing Olanzapine LAI Post-Injection Syndrome risks that includes a detailed product label including a post- injection observation period and an extensive healthcare provider training and educational program.

About Long-acting Injectable Antipsychotic Medications

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines state that poor or partial treatment compliance is a major problem in the long-term treatment of schi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
2. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
3. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
4. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
5. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
8. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
9. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
10. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...
(Date:12/15/2009)... Ill., Dec. 15 Fenwal Inc., a ... collection, separation, safety and availability, announced today that ... Fenwal approval to market InterSol ® platelet ... solution is a specialized product used in ... a vital blood component used to prevent or ...
(Date:12/15/2009)... 15 ,, Reportlinker.com announces that ... in its catalogue: ,, Hepatitis B ... to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... and Market Forecasts to 2015 ,, ... specialist,s new report, "Hepatitis B Vaccines - ...
Breaking Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Zimmer Holdings to Present at Upcoming Investor Conferences 55934 1St Anthonys Hospital Is First to Earn EPAS ENERGY STAR 28R 29 Symbol for Superior Energy Efficiency 55931 1St Anthonys Hospital Is First to Earn EPAS ENERGY STAR 28R 29 Symbol for Superior Energy Efficiency 55931 2St Anthonys Hospital Is First to Earn EPAS ENERGY STAR 28R 29 Symbol for Superior Energy Efficiency 55931 3Nevada Restaurant Self Insured Group Launches 24 Hour Injury Hotline on September 1 to Ensure Employee Safety 55928 1Nevada Restaurant Self Insured Group Launches 24 Hour Injury Hotline on September 1 to Ensure Employee Safety 55928 2
... Consumers Union Calls on Hospitals to Invest More ... WASHINGTON, Dec. 11 U.S. healthcare,facilities aren,t ... (MRSA) infections, according to,a new poll of infection ... conducted by the Association for Professionals in,Infection Control ...
... CITY, Calif., Dec. 11 /PRNewswire-FirstCall/,-- Bristol-Myers Squibb ... Sciences, Inc.,(Nasdaq: GILD ) today announced ... 200 mg/tenofovir disoproxil fumarate 300,mg) in Europe ... with,HIV-1 infection, subject to the product,s approval ...
Other Medicine Technology:Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 2Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 3Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 2Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 3Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 4Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 5Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 6Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 7Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe 8
(Date:12/15/2009)... would have really been in trouble, expert says , , ... the pandemic H1N1 swine flu has revealed serious flaws ... emergencies, a new report says. , The report, prepared ... Wood Johnson Foundation, also finds the dire economy has ... 2009 H1N1 outbreak is the latest in a series ...
(Date:12/15/2009)... MENLO PARK, Calif., Dec. 15 ... its position in the pharmaceutical and bio-tech ... (Caduceus Marketing Research). Over the past 11 ... panel, the Physicians Consulting Network (PCN®), which ... healthcare professionals covering both primary care and ...
(Date:12/15/2009)... SALT LAKE CITY, Dec. 15 The new ... and Fitness ( www.LifeSpanFitness.com ), was highly ... the best treadmills for 2010. The compact TR200 folding ... Design, and Best Treadmill under $1000. ,, The ... walking indoors in small workout spaces. "This category buster ...
(Date:12/15/2009)... such as tutoring children, can help older adults ... a study led by researchers at the Johns ... magnetic resonance imaging (fMRI), the researchers found that ... gains in key brain regions that support cognitive ... life. The study is the first of its ...
(Date:12/15/2009)... new employment opportunity for the unemployed or those needing additional income... ... America today. , ... Orlando, FL (PRWEB) December 15, ... agencies, is spreading holiday cheer and good will that is going ... created an opportunity for out of work Americans to get back ...
Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:For older adults, participating in social service activities can improve brain functions 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3
... Faster Than Annual ... Adjustment, WASHINGTON, Oct. 1 Earlier today, the,Centers for Medicare ... by 3.1 percent next year, to a total of,$96.40 per month ... jumped 93 percent since 2001, when premiums were just,$50.00 per month. ...
... the Mutter ... Museum, "Up the alley and down the street Fallon and Broom sell bones and meat., ... ... Need fresh cadavers? Fallon and,Broom are two, uh, gentlemen who would be happy to fulfill your ...
... 5 convenes national experts at unique forum to ... bullying prevention on Oct. 4 and 5, PITTSBURGH, Oct. 1 ... not due to illness; it is,because of a fear of being ... have been bullied mentally, verbally or,physically in school. Bullying is aggressive ...
... Calif. - An in vitro fertilization technique that can ... older than 35, according to researchers at the Stanford ... women in a retrospective study became pregnant after undergoing ... just one embryo into the womb. , Nearly 60 ...
... Critical Services ... to Over 1,000 in 5 days, SAN ... husband and wife team that makes up La Costa Dental,Excellence, a ... attention on the dental needs of their North,County patients. Recently Dr. ...
... Global, Inc.,(Pink Sheets: SNYL) has retained The Blaine ... At a time when there,s a major ... and build assisted-living housing for the,nation,s aging population, ... from China,s central government. "We are thrilled ...
Other Medicine News:Health News:Today's 2008 Medicare Part B Premium Announcement is Not Good News 2Health News:Wanted: Dead Bodies (Fresh, Preferably) 2Health News:Bullying Prevention Institute Designed to Empower Change in Schools 2Health News:Bullying Prevention Institute Designed to Empower Change in Schools 3Health News:IVF technique enables pregnancy without multiple births, Stanford researchers find 2Health News:San Diego Dentist Haunted by Smiles in Dominican Republic 2Health News:Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations 2
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... is precision, ergonomics, and value!, ... with soft non-slip, contoured handle , ... light plunger spring action , Completely ... without the need for recalibration , ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: